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Background: Human embryonic stem cells (hESCs) represent a tremendous resource for cell therapies and the
study of human development; however to maintain their undifferentiated state in vitro they routinely require the
use of mouse embryonic fibroblast (MEF) feeder-layers and exogenous protein media supplementation.
Results: These well established requirements can be overcome and in this study, it will be demonstrated that
phenotypic stability of hESCs can be maintained using a novel, human plasma protein-based hydrogel as an
extracellular culture matrix without the use of feeder cell co-culture. hESCs were resuspended in human platelet
poor plasma (PPP), which was gelled by the addition of calcium containing DMEM-based hESC culture medium.
Phenotypic and genomic expression of the pluripotency markers OCT4, NANOG and SOX2 were measured using
immunohistochemistry and qRT-PCR respectively. Typical hESC morphology was demonstrated throughout in vitro
culture and both viability and phenotypic stability were maintained throughout extended culture, up to 25
passages.
Conclusions: PPP-derived hydrogel has demonstrated to be an efficacious alternative to MEF co-culture with its
hydrophilicity allowing for this substrate to be delivered via minimally invasive procedures in a liquid phase with
polymerization ensuing in situ. Together this provides a novel technique for the study of this unique group of stem
cells in either 2D or 3D both in vitro and in vivo.
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Embryonic stem cells isolated from the inner cell mass
of pre-implantation embryos are recognised as the most
pluripotent of all stem cells and as a result of their dis-
tinctive cellular biology have an indefinite capacity to
self-renew and give rise to all cell types within the three
germ layers of a developing embryo [1] [2]. This unique
group of stem cells is therefore able to provide a com-
parable, manipulative platform to model the early stages
of human development. When hESCs are cultured dir-
ectly on tissue culture polystyrene (TCP) their distinct
phenotype is quickly lost with cells undergoing spontan-
eous differentiation characterised by a change in cell
morphology and loss of pluripotency markers, such as* Correspondence: f.lewis@liv.ac.uk
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reproduction in any medium, provided the orOCT4 and NANOG [1,3]. This indicates that their dis-
tinctive cell properties are influenced by their micro-
environment, thus stringent precisely defined culture
procedures have been developed as being fundamentally
required to maintain their unique characteristics
in vitro.
Conventionally, the pluripotency of hESCs has been
maintained through co-culture with feeder layers, most
commonly MEFs [4], however more recently human
feeder cells, such as human fetal muscle [4], human
foreskin fibroblasts [5], human uterine endometrial cells
and breast parenchymal cells [6] have been used success-
fully in an attempt to reduce xeno-components. Feeder
layers provide both contact signalling and essential ex-
ogenous proteins to enable hESCs to expand and self re-
new, however this approach is labour intensive and
often results in inconsistent experimental results, fur-
thermore co-cultivation with MEFs may expose hESCstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[7]. While the risk of transmission of murine virus
appears to be low, the potential for immune rejection as
a result of xeno-proteins does exist, therefore a com-
pletely human system is likely to be a prerequisite for
any cell-based clinical therapy. In order to make the
transition from the laboratory to clinic as simple as pos-
sible in vitro culture systems should also aim to satisfy
this criterion through reducing the use of xeno-
components where possible.
A number of cell culture regimes successfully use
materials during cell maintenance and expansion. Hydro-
gels are a particular group of polymeric materials that
have significant potential for use with cells as a carrier or
ECM as a result of their excellent cellular compatibility.
Hydrogels are a class of hydrophilic cross-linked poly-
mers, produced from either organic or inorganic compo-
nents with a typically >90% water content. This group of
materials can therefore provide an extracellular matrix
analogue substrate within or on which primary cells can
adhere and proliferate [8]. Their hydrophilicity and high
water content provides excellent mass transport proper-
ties to facilitate influx of soluble factors and efflux of
waste molecules, closely resembling the aqueous envir-
onment within native soft tissue [9]. Additionally, hydro-
gels can be delivered via minimally invasive procedures
in a liquid phase and then polymerised or gelled in situ.
The hydrogel engineered for this research utilised the
coagulation cascade to achieve gellation, providing cell
localisation and stability in vivo within 2 minutes post-
injection [10].
This unique approach to producing hydrogels for cell
culture involves the utilisation of host-derived blood
plasma to generate a matrix for cell maintenance and ex-
pansion [11]. The coagulation cascade, found natively in
blood, was exploited to form a stable organic hydrogelFigure 1 HESC Viability. Single field in which live/dead staining of hESCs
culture. A: Live cells (green). B: Dead cells (red). C: Nuclei (blue).under physiological conditions. Citration of whole blood
immediately post-venipuncture chelates free calcium
therefore halting coagulation. When the PPP component
of the blood is subsequently combined with any culture
media containing calcium ions, fibrinogenesis can re-
sume, resulting in a stable hydrogel, formed by the
donor’s native clotting system, incorporating the nutrient
rich culture media. Furthermore, the exogenous array of
growth factors, cytokines and other regulatory peptides
found within plasma removes the dependency on xeno-
genic animal serum from the cell culture matrix.
The PPP-derived hydrogel described herein has previ-
ously undergone validation in terms of its ability to
maintain the phenotype and expansion of primary der-
mal fibroblasts, articular chondrocytes and bone marrow
derived mesenchymal stem cells for multiple passages
in vitro [11]. In this study, we demonstrated for the first
time, the maintenance of hESCs in an undifferentiated
state whilst embedded in a feeder-free, PPP-derived
hydrogel construct, retaining both their pluripotent and
self- renewal capacity in vitro. The simplicity of this cul-
ture system along with the opportunities it presents in
culturing hESCs in a 3D environment has the potential
to advance biological efforts to understand the in vitro
self renewal of this unique group of cells, whilst meeting
the feeder-free demands of today’s research community.
Results
In vitro validation of PPP-derived hydrogel
A fundamental feature of any culture system is its cyto-
compatibility therefore hESCs embedded within this
hydrogel were subjected to live/dead staining in order to
validate if the hydrogel construct was able to provide an
environment capable of maintaining sufficient hESC via-
bility. Components of the cytotoxicity kit were found to
be freely permeable in the PPP hydrogel. Followingembedded within PPP-derived hydrogel is shown after 72 hours in
Figure 2 Cellular Morphology. Light microscopic observation of
confluent hESCs after 72 hours maintained in PPP-derived hydrogel
and on fibronectin. Scale bar represents 200 μm.
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fluoresce red (not shown) indicating that the hydrogel
does not inhibit the diffusion of the assay to the cells
embedded within the matrix.
Subsequent viability tests confirmed that hESCs cul-
tured within the PPP-derived hydrogel remained viable
(green fluorescence) over 72 hours in vitro. Although oc-
casionally cells fluorescing red were identified, indicating
the binding of ethidium bromide to the DNA of cells
with damaged membranes, this was rare and did not in-
dicate any unusual loss of cell viability (figure 1).
HESC morphology following culture in PPP-derived
hydrogel
Undifferentiated hESCs typically exhibit a high nucleus
to cytoplasm ratio and form colonies. hESCs embedded
within the hydrogel and cultured using DMEM/F12 as
detailed previously were observed to proliferate effect-
ively in vitro and had successfully formed colonies dis-
playing typical hESC morphology 24 hours following
their seeding within the hydrogel. Expansion of the
hESC populations continued until reaching confluency
after 72 hours as illustrated in figure 2.
Identification of pluripotency markers
Morphological analysis of hESCs embedded within the
hydrogel suggested that hESCs remained undifferenti-
ated. To confirm this observation, immunohistochemis-
try was performed on the seeded PPP-derived hydrogels
to identify pluripotency markers characteristic of hESC
undifferentiated phenotype: the transcription factors
OCT4, NANOG and SOX2, all of which are typically
expressed by undifferentiated hESCs in standard culture
[12-14] along with the surface antigen SSEA4 were high-
lighted as indicators of a pluripotent phenotype. All nu-
clear transcription factors were clearly identified up to
25 passages as illustrated in figure 3.
Expression of the pluripotency markers OCT4,
NANOG and SOX2, were also analysed at the gene level
by performing qRT-PCR. Both hESCs cultured under
PPP-derived hydrogel and fibronectin culture conditions
up to 10 passages were analysed. Expression of each of
these markers was identified in all samples.
Over the period of culture, expression of OCT4,
NANOG and SOX2 was comparable between both
hESCs maintained using both PPP-hydrogel and fibro-
nectin conditions over a number of passages with no sig-
nificant difference in transcript expression (figure 4).
Maintenance of hESC phenotype
HESCs maintained within the PPP-hydrogel were cul-
tured through 25 passages with no change in morph-
ology, viability or phenotype observed over the extended
period of culture (figure 5).Implantation of hESCs maintained up to passage 25
led to the formation of teratomas 6 weeks post-injection
observed both macroscopically and microscopically in
each case, n = 6. Derivatives of all three germ layers were
identified including endoderm-derived glandular struc-
tures, ectoderm –derived hair follicles and a variety of
mesoderm-derived structures including adipocytes, myo-
tubes and blood vessels. This provided further confirm-
ation that hESCs maintain their differentiation potential
when maintained using this novel PPP-derived hydrogel
culture system (figure 6).Discussion
Due to their distinctive biology, hESCs represent a
promising source of cells for modelling early develop-
ment and specific diseases whilst potentially providing a
source of replacement cells for a number of degenerative
diseases. However their culture, expansion and differen-
tiation requires further advancement in order to start to
Figure 3 Identification of Pluripotency Markers. Fluorescent observation of passage 25 hESCs immunohistochemically stained for OCT4,
NANOG, SOX2 (left), DAPI (centre), merged (right) under PPP-derived hydrogel conditions. Scale bar represents 50 μm.
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group of stem cells.
In an attempt to provide the optimum environment for
hESCs in vivo, the properties of the natural 3D micro-
environment should be considered as this provides both a
structural framework and morphogenic cues mediating
cell fate and function; natural extracellular matrices
(ECMs) are largely composed of protein fibres distributed
within a hydrated network of glycosaminoglycan chains[15] within this matrix are insoluble molecules, such as
fibronectin and laminin. In addition there are soluble
macromolecules, such as growth factors and cytokines,
which are potent stimulators driving cellular functions,
such as cell proliferation and differentiation [16-18].
The PPP-derived hydrogel possesses many ideal char-
acteristics which give it excellent cytocompatibility; such
as its 3D composition, mechanical integrity and mass
transport properties. In terms of its ability to maintain
Figure 4 Pluripotency Gene Expression. Quantification of pluripotency gene expression after culture under PPP-derived hydrogel and
fibronectin culture conditions at passage 1, 5 and 10. Error bars represent 1 standard deviation from the mean, n = 3.
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hydrogel construct may serve as an important mediator.
As previous studies have shown fibronectin plays an im-
portant role in embryonic development where it pro-
vides a substratum for guiding gastrulation and the
migration of neural crest cells [19]. While fibronectin is
one of the best studied non-collagenous ECM proteins it
is also moderately abundant in human blood plasma
where it contributes to blood clotting and wound heal-
ing [20] therefore it is likely that fibronectin within this
PPP-derived hydrogel permits the attachment of hESCs
through α5β1 integrin binding to RGD sites distributed
along fibronectin chains [21,22]. Both fibrinogen and fi-
brin also have multiple interacting sites serving asadhesion motifs, including binding sites for α5β1 integ-
rins [22], it is therefore also possible that the abundance
of fibrin within the hydrogel may also serve to mediate
successful attachment and proliferation of hESCs. In
addition the conversion of the soluble protein fibrinogen
to the insoluble protein fibrin during gellation generates
a network of fibres analogous to that found within nat-
ural ECM and in combination with the soluble growth
factors supplied in the culture media may serve to gen-
erate a microenvironment which effectively mimics the
histoarchitecture encountered in vivo thus promoting a
self-renewing, undifferentiated phenotype.
This investigation has demonstrated, for the first time,
the maintenance of hESCs in an undifferentiated state
Figure 5 Maintenance of hESC Phenotype. Light microscopic observation of hESC morphology after 25 passages maintained under PPP-
derived hydrogel conditions, nuclei stained with DAPI (blue).
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system retained both the pluripotency and self renewal
capacity of hESCs in vitro over long- term culture >25
passages, providing a novel system for the study of this
unique group of stem cells in vitro in 2 and 3 dimen-
sions. The components of this system are relatively inex-
pensive and straightforward to use, overcoming many of
the barriers currently hindering hESC research and mak-
ing this system an attractive alternative to currently
available feeder-free systems. Validation of this systemFigure 6 Teratoma Formation. Teratoma formation in immunodeficient m
layers. A: Macroscopic observation of teratoma formation. B: Glandular stru
follicles (ectoderm). D: Blood vessels (mesoderm). Scale bar represents 100was undertaken using the well characterised HUES7 cell
line, with no detrimental effects on their long- term
phenotypic stability observed. This opens up the possi-
bility of successfully using this system for the mainten-
ance of a wide variety of ESC lines.
Due to the incorporation of N2 and B27 supplements
in the culture media this system is not xeno-free there-
fore would not be considered suitable for clinical appli-
cation at present however further refinements would
open up the possibility of direct implantation of stemice demonstrates differentiation into derivatives of the three germ
ctures (endoderm). C: Muscle (mesoderm), adipose (mesoderm), hair
μm.
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previously been investigated in terms of immunogenicity
and minimal host immune cell recruitment upon injec-
tion in immunocompromised mice was observed. Fur-
thermore implantation of hESCs embedded within this
hydrogel may experience reduced immune responses as
a result of their segregation within this construct.
With a view to the future provision of autologous pluri-
potent cells, such as iPSCs, the culture system would be
ideal in many ways. Wide scale application for a broad
array of cell therapies may be established with the hydrogel
largely generated using a patient’s own plasma. While re-
search into iPSCs is still in its infancy it is likely that safer
ways of reprogramming somatic cells will be developed
and will thus require the same optimisation of cell culture
and maintenance as hESCs. Therefore a feeder-free,
potentially-autologous system such as this would provide a
platform for clinical translation of iPSCs.
Methods
Ethics statement
All research involving human participants was approved
by the Institutional Review Board of the University of
Liverpool. Following thorough discussion of the intent
and risks associated with the study, subjects gave written
informed consent to participate in this study.
Cell culture
The hESC line (HUES7) was obtained from Harvard Uni-
versity (hES Cell Facility/Melton Laboratory, MA, USA).
Initial populations were expanded on MEFs then subse-
quently seeded in feeder-free conditions on TCP dishes
pre-coated for 1 hour with 50 μg/ml of human plasma
fibronectin (Millipore, UK) solution at 37°C. The media
used to maintain hESCs in all cases was composed of
DMEM/F12 (Lonza, UK) basal medium supplemented with
10 ng/ml Activin A (R&D, UK), 4 ng/ml NT4 (Preprotech,
UK), 100 ng/ml bFGF (Autogen Bioclear, UK), N-2 supple-
ment, B-27 supplement, 1 mM L-glutamine, 1% NEAA,
0.1 mM beta-mercaptoethanol (Invitrogen, UK), 0.1% bo-
vine serum albumin (BSA) (Sigma, UK).
PPP isolation
20 mL of peripheral blood was isolated from 5
healthy donors of both genders under informed con-
sent via venipuncture and collected in sterile falcon
tubes. Immediately post-collection coagulation was
prevented by citration using 10% (v/v) 10 mM so-
dium citrate (Sigma Aldrich, UK). Citrated blood
samples were allowed to remain at room temperature
for 2 hours and then incubated at 42°C overnight.
After 12 hours the blood cells and plasma had largely
separated. Samples were centrifuged at 15 g for 10
minutes and the resulting supernatant decanted intoclean falcon tubes. The supernatant was centrifuged
at 15 g for 10 minutes and once again decanted, tak-
ing care not to disturb the cell pellet. Finally 0.22 μm
filtration was performed to ensure complete removal
of residual erythrocytes and maximal depletion of
platelets. The citrated PPP was then pooled and
stored at −20°C.PPP-derived hydrogel cell culture
The PPP-derived hydrogel was prepared from two dis-
tinct components, citrated PPP and hESC media. Both
components were pre-warmed to 37°C and the PPP
fraction added to the media at a concentration of
10% (v/v), and quickly mixed once to ensure a
homogenous amalgamation. The combined solution
was incubated for 5–10 minutes at 37°C, in a humidi-
fied atmosphere containing 5% CO2, allowing the for-
mation of a stable hydrogel. In order to capture
undifferentiated hESCs within the hydrogel construct,
citrated PPP was combined with a hESC suspension
containing 2.5 x 105 cells/mL at a concentration of
10% (v/v). This hydrogel/cell suspension was added to
individual wells of a 24 well plate at a volume of
1 mL/well and upon gellation at 37°C, 5% CO2 a
stable hydrogel was formed with hESCs dispersed
throughout. The hydrogel/hESC gels were cultured in
DMEM/F12 as detailed previously at 37°C, 5% CO2.
After reaching 70% confluency (approx 72 hours),
hESCs were passaged with 1x trypsin/EDTA (Invitrogen,
UK) for less than 1 minute at 37°C. The trypsinisation
reaction was then neutralised with an equal amount of
trypsin inhibitor (Invitrogen, UK) and this cell suspen-
sion was centrifuged at 400 g for 3 minutes at room
temperature. Once the resulting supernatant had been
aspirated the cell pellet was resuspended in hESC media
and once again encapsulated within a PPP-hydrogel.
hESCs were successfully cultured up to passage 25.Culture on fibronectin
A human fibronectin culture system, which has previ-
ously been validated in terms of its ability to maintain
the phenotype of hESCs over multiple passages in vitro
[23], was used to compare the novel hydrogel with an
established feeder-free culture system. This human fibro-
nectin system facilitates the undifferentiated expansion
of hESCs via β1-integrin attachment in DMEM/F12 con-
taining FGF2, activin A, neurotrophin 4, N2 and B27
supplements.
Plates were coated with 50 μg/mL human plasma
fibronectin solution and incubated for 1 hour at 37°C.
This solution was aspirated and hESCs were seeded at a
density of 7.5 x 105/mL. hESCs were maintained in
DMEM/F12 as detailed previously at 37°C, 5% CO2.
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The viability of hESCs cultured using this hydrogel system
was evaluated using Live/Dead Viability/Cytotoxicity Kit
(Molecular Probes, Invitrogen, UK). The individual compo-
nents of the kit, consisting of Calcein AM and ethidium
homodimer-1 (Ethd-1), were diluted in PBS to give final
working concentrations of 2 μM calcein AM and 4 μM
EthD-1. Nuclei were counter stained using Hoechst. One
hundred μl of each pre-diluted solution were added to
each well containing hydrogel-cell matrix and incubated
at 37°C for 30 minutes. An inverted fluorescent micro-
scope (Axiovert, Zeiss, UK) was used to visualise hESCs.
In order to confirm that the components of this assay
were able to diffuse throughout the hydrogel, so as to
successfully interact with the cells trapped within it, a
control was established whereby hESCs embedded
within the hydrogel were subjected to 70% ethanol
for 10 minutes, effectively inducing cell death.
Immunohistochemistry
All samples were fixed in situ with 4% (v/v) paraformal-
dehyde (Sigma Aldrich, UK) for 10 minutes at room
temperature. Samples were then blocked in a solution
of PBS with 10% serum (Invitrogen, UK) and 0.1%
Triton-X100 (Sigma Aldrich, UK) for 1 hour at room
temperature. Serum was specific to the animal in which
the secondary antibody was raised. Samples were then incu-
bated with a primary antibody or relevant isotype control
for 2 hours at 37°C diluted in animal serum at a concentra-
tion of 1% in PBS with Triton-X100 at a concentration of
0.1%. The working concentrations of the primary antibodies
used were as follows: OCT4 clone 10 monoclonal mouse
anti human IgG2b 1:500 (Santa Cruz), NANOG polyclonal
goat anti human IgG 1:200 (Cat. No. AF1997), SOX2 clone
245610 monoclonal mouse anti human IgG2a 1:100 (R&D
Systems, UK). Upon removing the primary antibody solu-
tion, hydrogel embedded samples were washed in PBS
three times for 5 minutes at room temperature and the
relevant secondary antibody: Alexafluor 594 goat anti
mouse IgG2b, Alexafluor 488 rabbit anti goat IgG and
Alexafluor 594 goat anti mouse IgG2a (Invitrogen, UK)
applied for 1 hour at 37°C. In order to remove any residual
secondary antibody, samples were washed three times for
5 minutes at room temperature then mounted onto a
microscope slide. To establish positive controls, hESCsTable 1 Primer sequences used in qRT-PCR




Β-Actin NM001101 GGACCTGACTGACTACCcultured using the fibronectin system were stained using
the same antibodies. In all samples cell nuclei were coun-
terstained with vector shield mounting medium contain-
ing the fluorescent stain 4’,6’-diamidino-2-phenylindole
(DAPI) (Vector Laboratories, UK) and each sample was
then observed immediately using laser- scanning confocal
microscopy (Carl Zeiss LSM 510).Real-time PCR (qRT-PCR)
Total cellular RNA was isolated from hESCs cultured
under both hydrogel and fibronectin conditions using
an RNeasy Mini Kit (Qiagen, UK) according to the man-
ufacturer’s recommendations and eluted in 30 μl of
RNase free water. The quantity and purity of RNA was
determined by 260/280 nm absorbance using a spectro-
photometer. For cDNA synthesis 2 μl of total RNA was
used as a template and reverse transcription was per-
formed using SuperScriptTM III and OligodT primers
(Invitrogen, UK). For subsequent RT-PCR reactions
cDNA synthesised from the reverse transcription reac-
tion was diluted 10 fold with ultraPURE DNase and
RNase free ddH2O (Invitrogen, UK).
All primers were designed in house to amplify the fol-
lowing pluripotency associated genes: OCT4, NANOG,
and SOX2 while the housekeeping gene β-actin was also
amplified to act as a reference. Primers are detailed in
Table 1. After optimisation of the primers to ensure
their efficiency and ability to amplify a single PCR prod-
uct, qRT-PCR was performed on all samples including
negative controls using a thermocycler (Bio-Rad, UK)
and a stock solution containing SYBR Green single tube
real time master mix (Bio-Rad, UK), ultraPURE ddH2O
and a primer solution containing both sense and anti-
sense custom designed primers (Invitrogen, UK). Briefly,
samples were denatured for 3 minutes at 95°C then
cycled 40 times at 95°C for 30 seconds, followed by
40 cycles at the primer specific annealing temperature
ranging from 53°C to 57°C, 55°C for 30 seconds, 95°C
for 30 seconds and finally 40 cycles at 55°C for 10
seconds. Triplicate readings were taken for each ex-
perimental sample and normalised against the refer-
ence gene β-actin. The fold change of each target gene
was then calculated using 2 –(ΔCT sample –ΔCT control) were
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hESCs were maintained within PPP-derived hydrogels
to passage 10, harvested using trypsin then resuspended
in an appropriate volume of hESC media. Pre-warmed
PPP was added at a volume of 10% just prior to im-
plantation and gellation ensued in situ under physio-
logical conditions. Six week old, male immunodeficient
CH1 mice received four injections into subcutaneous
tissue above each shoulder and hip joint with each site
receiving 10x6 hESCs contained within 300μL PPP-
derived hydrogel solution. Animals were sacrificed at 4,
6 and 8 weeks post-implantation. All in vivo experimen-
tal procedures were conducted in accordance with UK
Home Office regulations under licence and were
approved by Research Ethics Committee. Tumours were
fixed in periodate-lysine-paraformaldehyde fixative for
7 days at 4°C then into cold washing solution for 24
hours at 4°C. Cold acetone was applied to dehydrate
samples for a further 5 days at 4°C before replacing with
cold Technovit infiltration solution (Heraeus Kulzer) for
1 week at 4°C. This was then replaced with cold Tech-
novit resin embedding solution (Heraeus Kulzer) and
the resin surface covered with mineral oil (Sigma
Aldrich, UK) for 5 days at −55°C. The temperature was
then slowly increased first to −20°C for 2 days then
brought to room temperature to allow polymerisation of
the tissue blocks. Sections were cut to 6 μM using a
polycut microtome and placed onto APTES coated
slides. Histological analysis was performed using
hematoxylin/eosin staining and observed using trans-
mitted light microscopy.
Statistical analysis
Statistical analysis was performed using SPSS (SYSTAT
Software Inc.) to determine differences in gene expression
between the two systems. Samples were evaluated by per-
forming a Mann–Whitney U test with a p-value of <0.05
being considered statistically significant. In each experi-
ment triplicate qRT-PCR reactions were performed for
each individual sample and the average of these values
taken to reduce experimental error. The results presented
here were obtained from three separate experiments, n=3
for each time point.
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